Target intelligence / Profile preview

Tapeworm tegument and mitochondrial proteins

Molecular classification
Other, Enzyme, Transporter, Structural protein, Antigen
01

Overview

Tegument proteins of tapeworms form the outer body covering, interfacing directly with the host environment, mediating nutrient uptake, protection from host immunity, and metabolism. The tegument is a syncytial structure containing various proteins including enzymes (e.g., phosphatases, peptidases), transporters, structural proteins (actin, tubulin), and antigenic surface molecules (tetraspanins, GP50, EG95). Mitochondrial proteins in tapeworms are central to the parasite’s energy metabolism and contribute to drug response pathways. Many of these proteins are unique to tapeworms or significantly divergent from host homologs, making them targets for antihelminthic drugs (e.g., praziquantel, mebendazole), vaccines, and diagnostics. However, the target grouping "Tapeworm tegument and mitochondrial proteins" is too general for specific pharmacological intervention and instead encompasses numerous potential targets currently under research and development.

Other names
Tapeworm surface proteinsCestode tegument proteinsTapeworm mitochondrial proteinsTapeworm antigensCestode glycolytic enzymes
02

Mechanism of action

Disruption of tegument integrity and ion transport (e.g., praziquantel increases Ca2+ permeability, causing paralysis/death) Inhibition of tubulin polymerization (mebendazole/benzimidazoles) Inhibition of mitochondrial electron transport/energy production (niclosamide) Immune stimulation or antigen targeting (vaccines based on surface/tegument antigens provoke host response)

03

Biological functions

Host-parasite interfaceNutrient absorptionSignal transductionDetoxificationEnergy metabolismMotility and structural maintenance
04

Disease associations

InfectionImmune evasionOther
05

Safety considerations

Off-target toxicity due to evolutionary conservation of cytoskeletal and mitochondrial proteins between parasite and host (e.g., tubulin, actin)Immune reactions (inflammatory or allergic responses to parasite antigens)Drug resistance development (target mutations or upregulation of detoxification pathways)
06

Interacting drugs

Praziquantel

4 more in the full profile.

07

Biomarkers

Surface/tegument antigens for serological diagnosis (e.g., GP50, EG95, RT10, tetraspanins)Enzyme activity or protein signatures detectable by immunoassay for infection status or vaccine efficacy

Beyond the preview

Go deeper on Tapeworm tegument and mitochondrial proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tapeworm tegument and mitochondrial proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call